About CorNeat Vision 

ISO.PNG

We are an innovative medical device company with an overarching mission of promoting human health, sustainability and equality worldwide.

Our lineup of biomimetic implants blends novel bio-integration technology with innovative ideas to create groundbreaking solutions that address unmet needs in the areas of ophthalmology and periodontology. Our current products biomechanically incorporate with resident tissue providing safe, aesthetic and long-lasting remedies for corneally blind patients and those suffering from glaucoma. These include the CorNeat KPro (artificial cornea), the CorNeat EverPatch (synthetic tissue patch) and the CorNeat eShunt (glaucoma drainage device).

רקע כהה למעלה

Our Mission 

Our mission is to promote health and equality worldwide through innovative biomimetic medical solutions that are widely accessible.

Our goal at CorNeat Vision is to innovate and grow, as well as leverage the power of partnerships to introduce biomimetic implants that aim to permanently resolve medical and surgical challenges in diversified therapeutic fields.

Finding solutions to medical problems is extremely challenging. CorNeat Vision promotes permanent solutions to medical problems through an active learning process, putting the physician's ease of use as one of our top priorities.

In order to fulfill our vision we promote the following core values:

Innovation: Out-of-the-box thinking is our way of life. We believe in revolutionary thinking across our operations and do not adopt existing practices, systems, processes, and solutions without truly challenging them. We believe in a multi-disciplinary approach to problem solving and encourage diversified thinking.

Team: Our employees are our most valuable resource. We promote learning and personal development of our staff while making sure they all feel at home, included and united. The team works inclusively, in cooperation, leveraging individual talent and mutual inspiration to achieve excellence.

Equality: We believe that everyone has the right to medical care therefore we leverage our business development, distribution power, clinical operations and training activities to introduce and offer our solutions in developing and impoverished countries.

Customer Focus: Our primary customers are patients and physicians who use our products. We prioritize physician experience and ease of use.  We value aesthetics and its importance to our customer base (physicians and patients) and aim to develop solutions that respect this.

Quality: We constantly invest in improving the quality of our products and processes with an aim to exceed customer expectations.

 

Management Team

Experienced team with a multi-disciplinary background 

Gilad Litvin, MD

Co-Founder, Chairman, Chief Medical Officer

Gil Lotan, Adv.

VP Business Development

Almog Aley-Raz

Co-Founder, Chief Executive Officer, VP of Research and Development

Sapir Buchris, Adv.

VP Operations & Corporate Development

Gerry Tal

VP Quality, Regulatory and Clinical Affairs

 
רקע כהה למעלה

Ophthalmic Advisory Board

Our Advisory Board consists of the world’s top ophthalmologists and ophthalmic innovators in cornea, glaucoma, and anterior chamber devices and surgery. They are key opinion leaders from Israel, Canada, US, France, and China, who will take an active role in our clinical trials and subsequent regulatory submissions. Together, they have published over 650 peer reviewed papers. 
 

Ehud Assia, MD

Israel

Zuguo Liu, MD, PhD

China

R. Doyle Stulting, MD, PhD

United States

David Rootman, MD, FRCSC

Canada

Ike Ahmed, MD, FRCSC

Canada

Eric Gabison, MD, PhD

France

Edward J. Holland, MD

United States

 

Principal Investigators

Top-tier physicians from around the world currently lead the clinical trials of the CorNeat KPro and the CorNeat EverPatch. In addition to our scientific advisory board, whose members take an active role in the current and planned clinical trials, we are also fortunate to partner with the following principal investigators.

Irit Bahar, MD, MHA

CorNeat KPro

Product:

Clinical site:

Rabin Medical Center,
Petah Tikva, Israel

Site status:

Recruiting

Rudy Nuijts, MMA

CorNeat KPro

Product:

Clinical site:

Maastricht UMC+,
Maastricht, Netherlands

Site status:

Recruiting

Lily Adhiambo Nyamai, MBChB, FCOECSA

CorNeat EverPatch

Product:

Clinical site:

Kenyatta National Hospital
Lions SightFirst Hospital
Nairobi, Kenya

Site status:

Recruiting

Alfonso iovieno, MD, PhD FRCSC

CorNeat KPro

Product:

Clinical site:

University of British Columbia,
Canada

Site status:

Recruiting

Ruth Lapid-Gortzak, MD, PhD

CorNeat KPro

Product:

Clinical site:

Amsterdam UMC,
Amsterdam, Netherlands

Site status:

Recruiting

Helen Roberts, MBE FRCOphth

CorNeat EverPatch

Product:

Clinical site:

Kwale Eye Hospital,
Mombasa, Kenya

Site status:

Recruiting

Clara C. Chan, MD, FRCSC, FACS

CorNeat KPro

Product:

Clinical site:

University Health Network,
Ontario, Canada

Site status:

Recruiting

Vincent Daien, MD, PhD, FEBO

CorNeat KPro

Product:

Clinical site:

CHU de Montpellier,
Montpellier, France

Site status:

Recruiting

 

Awards & Accreditations

Most Innovative Ophthalmic Implant Developers - Israel

MIXiii BIOMED Startup of the Year Award

EU Horizon 2020 Seal of Excellence 2017

EU Horizon 2020 Seal of Excellence Award 2020

Xi’an International Startup Competition, Second Prize Winner

CorNeat Vision Wins the Finals of China (Shenzhen) Innovation & Entrepreneurship Int’l Competition

EU Horizon 2020 Seal of Excellence 2018

 
 
רקע כהה למעלה

Scientific Collaboration

Toam Katz, MD

Germany

Major Milestones